Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Fox

Showing results (181-190 of 258) with videos related to

Pageof 26
Sort By:
Pathology|March 18, 2025
Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of AustralasiaWendy A Cooper, Benhur Amanuel, Caroline Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737Samantha R Oakes, François Vaillant, Elgene Lim, et al.
Cancer Research|February 3, 2019
CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial CellsTara Karnezis, Rae H Farnsworth, Nicole C Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcomeRichard W Tothill, Anna V Tinker, Joshy George, et al.
Journal of the National Cancer Institute|April 6, 2019
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast CancerNa Li, Simone McInerny, Magnus Zethoven, et al.
NPJ Breast Cancer|August 18, 2020
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic densityDane Cheasley, Lisa Devereux, Siobhan Hughes, et al.
Molecular Cancer Therapeutics|June 15, 2017
Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell CarcinomaClare E Weeden, Aliaksei Z Holik, Richard J Young, et al.
Breast Cancer Research : BCR|January 25, 2011
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu, Max Yan, Jennifer Patra, et al.
Histopathology|September 9, 2015
Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical managementEmad A Rakha, Sunil Badve, Vincenzo Eusebi, et al.
Cancer Cell|February 21, 2012
VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endotheliumTara Karnezis, Ramin Shayan, Carol Caesar, et al.
Pageof 26

Showing results (181-190 of 258) with videos related to

Sort By:
Pageof 26
Pathology|March 18, 2025
Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of AustralasiaWendy A Cooper, Benhur Amanuel, Caroline Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737Samantha R Oakes, François Vaillant, Elgene Lim, et al.
Cancer Research|February 3, 2019
CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial CellsTara Karnezis, Rae H Farnsworth, Nicole C Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcomeRichard W Tothill, Anna V Tinker, Joshy George, et al.
Journal of the National Cancer Institute|April 6, 2019
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast CancerNa Li, Simone McInerny, Magnus Zethoven, et al.
NPJ Breast Cancer|August 18, 2020
The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic densityDane Cheasley, Lisa Devereux, Siobhan Hughes, et al.
Molecular Cancer Therapeutics|June 15, 2017
Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell CarcinomaClare E Weeden, Aliaksei Z Holik, Richard J Young, et al.
Breast Cancer Research : BCR|January 25, 2011
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu, Max Yan, Jennifer Patra, et al.
Histopathology|September 9, 2015
Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical managementEmad A Rakha, Sunil Badve, Vincenzo Eusebi, et al.
Cancer Cell|February 21, 2012
VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endotheliumTara Karnezis, Ramin Shayan, Carol Caesar, et al.
Pageof 26